Subliminal Laser
Therapy for Retinal
Disorders

How to treat retina today?

subliminal laser therapy treatment application

For a quarter of a century, laser photocoagulation has been considered a safe and effective treatment option for macular pathologies. Over the years, the development and introduction of new and innovative macular laser technologies has confirmed that, alongside intravitreal injections, photocoagulation laser therapy still plays a valuable role in the surgeons’ treatment armamentarium.

Today, ophthalmologists can offer their patients enhanced retinal treatment options, with greater safety and efficacy than ever before.

*Image courtesy of Alejandro Filloy Rius, MD, Ph.D. – Tarragona, Spain

retina image subliminal laser therapy treatment

Subliminal laser therapy:

Unlike conventional thermal laser, Subliminal laser therapy is a non-damaging treatment mode based on a train of microsecond pulses.

It involves a series of repetitive laser pulses with intervals (cooling times) and produces a therapeutic treatment effect without inducing scarring or RPE damage on clinical examination during or after treatment.

Its use is dedicated to the treatment of macular diseases.

There remains an unmet need in the treatment of macular diseases. Increasing evidence demonstrates SubLiminal laser therapy to be safe and effective for macular conditions such as DME and CSC.

Several studies demonstrate that retinal destruction was required to control the neovascularization process in PDR. For peripheral conditions Multispot laser photocoagulation should be favored.

Easily access to our clinical database

Find our latest clinical data regarding subliminal laser therapy

LATEST CLINICAL DATA

Access a range of clinical educational content, to all the clinical content available about for both macula and peripheral treatments, including: clinical articles, clinical videos, treatment guidelines…
SYMPO LASER EURETINA
Play button

Laser for retina and vitreous: all you need to know in 2023

27/10/2023
subli article

SubLiminal Laser Therapy for CSCR

12/12/2023
A new front-line treatment
Laser to Drusen in AMD

Laser to Drusen in AMD

13/02/2023
Laser photocoagulation can improve vision by promoting resorption of the drusen.
PIE SOLS symposium 2022 12 min

Experts Layout Guidelines for Subthreshold Laser Treatment

23/11/2022
Many countries are unable to afford continuous unending intravitreal injections for macular diseases,” said Dr. Kenneth Fong. Building the case for the use of subthreshold laser (STL) treatment and its application for retinal diseases, Dr. Fong and two other vitreoretinal doctors presented at a symposium on behalf of The Subthreshold Ophthalmic Laser Society (SOLS) at the recently held CAKE & PIE Expo 2.0 in Da Nang, Vietnam.
Subthreshold laser therapy guidelines for retinal diseases

Subthreshold laser therapy guidelines for retinal diseases

19/09/2022
Subthreshold laser therapy has been utilised in clinical practice for more than three decades, and numerous randomised and real-life studies has proven its efficacy and safety in various retinal diseases. However, despite decades of usage, we still do not have a standard protocol for subthreshold laser applications and settings.
subli article

SubLiminal Laser Therapy for CSCR

12/12/2023
A new front-line treatment
Laser to Drusen in AMD

Laser to Drusen in AMD

13/02/2023
Laser photocoagulation can improve vision by promoting resorption of the drusen.

by

Quantel Medical & Ellex, 2 brands of Lumibird Medical, united with 1 objective: develop cutting-edge technologies for the diagnosis and treatment of dry eye and leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.

Newsletter

"*" indicates required fields

Name
The information collected through this form is recorded and transmitted to the relevant QUANTEL MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to QUANTEL MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at rgpd@quantelmedical.fr.
Country*
Personal data compliance
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.
© 2024 Quantel Medical
Share this page by email
Share this page on facebook
Share this page on twitter
Share this page on linkedin